Journal of Clinical Endocrinology & Metabolism, Vol 78, 1312-1319, Copyright © 1994 by Endocrine Society

ARTICLES

Enhanced sensitivity growth hormone (GH) chemiluminescence assay reveals lower postglucose nadir GH concentrations in men than women

IM Chapman, ML Hartman, M Straume, ML Johnson, JD Veldhuis and MO Thorner
Department of Medicine, University of Virginia Health Sciences Center, Charlottesville 22908.

Modifications were made to a commercially available human (h) GH chemiluminescence assay (Nichols Luma Tag hGH assay), which improved its sensitivity to 0.002 micrograms/L. The results of this assay had a high correlation with those of the Nichols hGH immunoradiometric assay (IRMA; r = 0.91; P < 0.001). The addition of recombinant hGH-binding protein (0.1-10 nmol/L) to standards and serum samples caused a dose- responsive reduction in measured GH in both the chemiluminescence assay and the IRMA; at physiological concentrations of hGH-binding protein, a 10-20% reduction was observed. Fifteen normal young adults (nine men and six women) underwent a standard 100-g oral glucose tolerance test, and plasma GH was measured from 30 min before until 5 h after glucose ingestion. GH was measurable in all samples with the chemiluminescence assay, but fell below the sensitivity of the IRMA in 59% of the samples. There was no difference between baseline or peak glucose levels in male and female subjects, but serum GH concentrations (mean +/- SD) measured by the enhanced sensitivity chemiluminescence assay were lower in male than female subjects at both baseline (0.12 +/- 0.08 vs. 2.3 +/- 2.3 micrograms/L; P < 0.01) and the postglucose GH nadir (0.029 +/- 0.014 vs. 0.25 +/- 0.23 micrograms/L; P < 0.01). The high correlation between baseline and nadir GH (r = 0.82; P < 0.001) and the equivalent fractional decline in mean GH levels in men and women after glucose administration (67 +/- 17% vs. 84 +/- 8%; P = 0.06) suggest that the lower GH levels in men after glucose treatment are due to lower baseline values and not to a greater suppressive effect of glucose.

This article has been cited by other articles:

				R. Nass, S. S. Pezzoli, M. C. Oliveri, J. T. Patrie, F. E. Harrell Jr., J. L. Clasey, S. B. Heymsfield, M. A. Bach, M. L. Vance, and M. O. Thorner Effects of an Oral Ghrelin Mimetic on Body Composition and Clinical Outcomes in Healthy Older Adults: A Randomized Trial Ann Intern Med, November 4, 2008; 149(9): 601 - 611. [Abstract] [Full Text] [PDF]

				P. Kok, F. Roelfsema, M. Frolich, J. van Pelt, A. E. Meinders, and H. Pijl Short-Term Treatment with Bromocriptine Improves Impaired Circadian Growth Hormone Secretion in Obese Premenopausal Women J. Clin. Endocrinol. Metab., September 1, 2008; 93(9): 3455 - 3461. [Abstract] [Full Text] [PDF]

				M. Misra, J. Cord, R. Prabhakaran, K. K. Miller, and A. Klibanski Growth Hormone Suppression after an Oral Glucose Load in Children J. Clin. Endocrinol. Metab., December 1, 2007; 92(12): 4623 - 4629. [Abstract] [Full Text] [PDF]

				R Giordano, A Picu, L Bonelli, F Broglio, F Prodam, S Grottoli, G Muccioli, E Ghigo, and E Arvat The activation of somatostatinergic receptors by either somatostatin-14 or cortistatin-17 often inhibits ACTH hypersecretion in patients with Cushing's disease Eur. J. Endocrinol., October 1, 2007; 157(4): 393 - 398. [Abstract] [Full Text] [PDF]

				L. Wideman, L. Consitt, J. Patrie, B. Swearingin, R. Bloomer, P. Davis, and A. Weltman The impact of sex and exercise duration on growth hormone secretion J Appl Physiol, December 1, 2006; 101(6): 1641 - 1647. [Abstract] [Full Text] [PDF]

				H. Markkanen, T. Pekkarinen, M. J. Valimaki, H. Alfthan, R. Kauppinen-Makelin, T. Sane, and U.-H. Stenman Effect of Sex and Assay Method on Serum Concentrations of Growth Hormone in Patients with Acromegaly and in Healthy Controls Clin. Chem., March 1, 2006; 52(3): 468 - 473. [Abstract] [Full Text] [PDF]

				J. J. Puder, S. Nilavar, K. D. Post, and P. U. Freda Relationship between Disease-Related Morbidity and Biochemical Markers of Activity in Patients with Acromegaly J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 1972 - 1978. [Abstract] [Full Text] [PDF]

				M. Misra, K. K. Miller, D. B. Herzog, K. Ramaswamy, A. Aggarwal, C. Almazan, G. Neubauer, J. Breu, and A. Klibanski Growth Hormone and Ghrelin Responses to an Oral Glucose Load in Adolescent Girls with Anorexia Nervosa and Controls J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1605 - 1612. [Abstract] [Full Text] [PDF]

				P. U. Freda, A. T. Nuruzzaman, C. M. Reyes, R. E. Sundeen, and K. D. Post Significance of "Abnormal" Nadir Growth Hormone Levels after Oral Glucose in Postoperative Patients with Acromegaly in Remission with Normal Insulin-Like Growth Factor-I Levels J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 495 - 500. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. Patrie, L. Wideman, M. Patterson, J. Y. Weltman, and A. Weltman Contrasting Negative-Feedback Control of Endogenously Driven and Exercise-Stimulated Pulsatile Growth Hormone Secretion in Women and Men J. Clin. Endocrinol. Metab., February 1, 2004; 89(2): 840 - 846. [Abstract] [Full Text] [PDF]

				D. R. Clemmons, K. Chihara, P. U. Freda, K. K. Y. Ho, A. Klibanski, S. Melmed, S. M. Shalet, C. J. Strasburger, P. J. Trainer, and M. O. Thorner Optimizing Control of Acromegaly: Integrating a Growth Hormone Receptor Antagonist into the Treatment Algorithm J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4759 - 4767. [Abstract] [Full Text] [PDF]

				R. Nass, S. S. Pezzoli, I. M. Chapman, J. Patrie, R. L. Hintz, M. L. Hartman, and M. O. Thorner IGF-I does not affect the net increase in GH release in response to arginine Am J Physiol Endocrinol Metab, October 1, 2002; 283(4): E702 - E710. [Abstract] [Full Text] [PDF]

				P. J. Trainer Acromegaly--Consensus, What Consensus? J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3534 - 3536. [Full Text] [PDF]

				A. C. F. Costa, A. Rossi, C. E. Martinelli Jr., H. R. Machado, and A. C. Moreira Assessment of Disease Activity in Treated Acromegalic Patients Using a Sensitive GH Assay: Should We Achieve Strict Normal GH Levels for a Biochemical Cure? J. Clin. Endocrinol. Metab., July 1, 2002; 87(7): 3142 - 3147. [Abstract] [Full Text] [PDF]

				A. Kehely, P. C. Bates, P. Frewer, M. Birkett, W. F. Blum, P. Mamessier, S. Ezzat, K. K. Y. Ho, G. Lombardi, A. Luger, et al. Short-Term Safety and Efficacy of Human GH Replacement Therapy in 595 Adults with GH Deficiency: A Comparison of Two Dosage Algorithms J. Clin. Endocrinol. Metab., May 1, 2002; 87(5): 1974 - 1979. [Abstract] [Full Text] [PDF]

				C. Parkinson, W. D. J. Ryder, and P. J. Trainer The Relationship between Serum GH and Serum IGF-I in Acromegaly Is Gender-Specific J. Clin. Endocrinol. Metab., November 1, 2001; 86(11): 5240 - 5244. [Abstract] [Full Text] [PDF]

				W. M. Drake, S. J. Howell, J. P. Monson, and S. M. Shalet Optimizing GH Therapy in Adults and Children Endocr. Rev., August 1, 2001; 22(4): 425 - 450. [Abstract] [Full Text] [PDF]

				J. L. Clasey, A. Weltman, J. Patrie, J. Y. Weltman, S. Pezzoli, C. Bouchard, M. O. Thorner, and M. L. Hartman Abdominal Visceral Fat and Fasting Insulin Are Important Predictors of 24-Hour GH Release Independent of Age, Gender, and Other Physiological Factors J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3845 - 3852. [Abstract] [Full Text] [PDF]

				P. Marzullo, C. Di Somma, K. L. Pratt, J. Khosravi, A. Diamandis, G. Lombardi, A. Colao, and R. G. Rosenfeld Usefulness of Different Biochemical Markers of the Insulin-Like Growth Factor (IGF) Family in Diagnosing Growth Hormone Excess and Deficiency in Adults J. Clin. Endocrinol. Metab., July 1, 2001; 86(7): 3001 - 3008. [Abstract] [Full Text] [PDF]

				G. A. Kaltsas, A. M. Isidori, D. Florakis, P. J. Trainer, C. Camacho-Hubner, F. Afshar, I. Sabin, J. P. Jenkins, S. L. Chew, J. P. Monson, et al. Predictors of the Outcome of Surgical Treatment in Acromegaly and the Value of the Mean Growth Hormone Day Curve in Assessing Postoperative Disease Activity J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1645 - 1652. [Abstract] [Full Text]

				J. A. Gusenoff, S. M. Harman, J. D. Veldhuis, J. J. Jayme, C. St. Clair, T. Munzer, C. Christmas, K. G. O'Connor, T. E. Stevens, M. F. Bellantoni, et al. Cortisol and GH secretory dynamics, and their interrelationships, in healthy aged women and men Am J Physiol Endocrinol Metab, April 1, 2001; 280(4): E616 - E625. [Abstract] [Full Text] [PDF]

				S. R. Peacey, A. A. Toogood, J. D. Veldhuis, M. O. Thorner, and S. M. Shalet The Relationship between 24-Hour Growth Hormone Secretion and Insulin-Like Growth Factor I in Patients with Successfully Treated Acromegaly: Impact of Surgery or Radiotherapy J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 259 - 266. [Abstract] [Full Text]

				L. Wideman, J. Y. Weltman, J. T. Patrie, C. Y. Bowers, N. Shah, S. Story, A. Weltman, and J. D. Veldhuis Synergy of L-arginine and growth hormone (GH)-releasing peptide-2 on GH release: influence of gender Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1455 - R1466. [Abstract] [Full Text] [PDF]

				C. J. Pritzlaff, L. Wideman, J. Blumer, M. Jensen, R. D. Abbott, G. A. Gaesser, J. D. Veldhuis, and A. Weltman Catecholamine release, growth hormone secretion, and energy expenditure during exercise vs. recovery in men J Appl Physiol, September 1, 2000; 89(3): 937 - 946. [Abstract] [Full Text] [PDF]

				A. Weltman, C. J. Pritzlaff, L. Wideman, J. Y. Weltman, J. L. Blumer, R. D. Abbott, M. L. Hartman, and J. D. Veldhuis Exercise-dependent growth hormone release is linked to markers of heightened central adrenergic outflow J Appl Physiol, August 1, 2000; 89(2): 629 - 635. [Abstract] [Full Text] [PDF]

				J. D. Veldhuis, J. N. Roemmich, and A. D. Rogol Gender and Sexual Maturation-Dependent Contrasts in the Neuroregulation of Growth Hormone Secretion in Prepubertal and Late Adolescent Males and Females--A General Clinical Research Center-Based Study J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2385 - 2394. [Abstract] [Full Text]

				A. Giustina, A. Barkan, F. F. Casanueva, F. Cavagnini, L. Frohman, K. Ho, J. Veldhuis, J. Wass, K. von Werder, and S. Melmed Criteria for Cure of Acromegaly: A Consensus Statement{dagger} J. Clin. Endocrinol. Metab., February 1, 2000; 85(2): 526 - 529. [Abstract] [Full Text]

				M. R. DRANGE, N. R. FRAM, V. HERMAN-BONERT, and S. MELMED Pituitary Tumor Registry: A Novel Clinical Resource J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 168 - 174. [Abstract] [Full Text]

				M. Bergendahl, A. Iranmanesh, W. S. Evans, and J. D. Veldhuis Short-Term Fasting Selectively Suppresses Leptin Pulse Mass and 24-Hour Rhythmic Leptin Release in Healthy Midluteal Phase Women without Disturbing Leptin Pulse Frequency or Its Entropy Control (Pattern Orderliness) J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 207 - 213. [Abstract] [Full Text]

				D. M. Cook, W. H. Ludlam, and M. B. Cook Route of Estrogen Administration Helps to Determine Growth Hormone (GH) Replacement Dose in GH-Deficient Adults J. Clin. Endocrinol. Metab., November 1, 1999; 84(11): 3956 - 3960. [Abstract] [Full Text]

				J. A. Kanaley, M. M. Weatherup-Dentes, E. B. Jaynes, and M. L. Hartman Obesity Attenuates the Growth Hormone Response to Exercise J. Clin. Endocrinol. Metab., September 1, 1999; 84(9): 3156 - 3161. [Abstract] [Full Text]

				P. C. Hindmarsh, E. Dennison, S. M. Pincus, C. Cooper, C. H. D. Fall, D. R. Matthews, P. J. Pringle, and C. G. D. Brook A Sexually Dimorphic Pattern of Growth Hormone Secretion in the Elderly J. Clin. Endocrinol. Metab., August 1, 1999; 84(8): 2679 - 2685. [Abstract] [Full Text]

				M. O. Thorner, C. J. Strasburger, Z. Wu, M. Straume, M. Bidlingmaier, S. S. Pezzoli, K. Zib, J. C. Scarlett, and W. F. Bennett Growth Hormone (GH) Receptor Blockade with a PEG-Modified GH (B2036-PEG) Lowers Serum Insulin-Like Growth Factor-I but Does Not Acutely Stimulate Serum GH J. Clin. Endocrinol. Metab., June 1, 1999; 84(6): 2098 - 2103. [Abstract] [Full Text]

				E. E. Muller, V. Locatelli, and D. Cocchi Neuroendocrine Control of Growth Hormone Secretion Physiol Rev, April 1, 1999; 79(2): 511 - 607. [Abstract] [Full Text] [PDF]

				M. Bergendahl, W. S. Evans, C. Pastor, A. Patel, A. Iranmanesh, and J. D. Veldhuis Short-Term Fasting Suppresses Leptin and (Conversely) Activates Disorderly Growth Hormone Secretion in Midluteal Phase Women--A Clinical Research Center Study J. Clin. Endocrinol. Metab., March 1, 1999; 84(3): 883 - 894. [Abstract] [Full Text]

				A. Giustina and J. D. Veldhuis Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human Endocr. Rev., December 1, 1998; 19(6): 717 - 797. [Abstract] [Full Text]

				P. U. Freda, K. D. Post, J. S. Powell, and S. L. Wardlaw Evaluation of Disease Status with Sensitive Measures of Growth Hormone Secretion in 60 Postoperative Patients with Acromegaly J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 3808 - 3816. [Abstract] [Full Text]

				H. G. Maheshwari, B. L. Silverman, J. Dupuis, and G. Baumann Phenotype and Genetic Analysis of a Syndrome Caused by an Inactivating Mutation in the Growth Hormone-Releasing Hormone Receptor: Dwarfism of Sindh J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4065 - 4074. [Abstract] [Full Text]

				S. Melmed Tight Control of Growth Hormone: An Attainable Outcome for Acromegaly Treatment J. Clin. Endocrinol. Metab., October 1, 1998; 83(10): 3409 - 3410. [Full Text]

				S. Melmed, I. Jackson, D. Kleinberg, and A. Klibanski Current Treatment Guidelines for Acromegaly J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2646 - 2652. [Abstract] [Full Text]

				I. M. Chapman, M. L. Hartman, K. S. Pieper, E. H. Skiles, S. S. Pezzoli, R. L. Hintz, and M. O. Thorner Recovery of Growth Hormone Release from Suppression by Exogenous Insulin-Like Growth Factor I (IGF-I): Evidence for a Suppressive Action of Free Rather Than Bound IGF-I J. Clin. Endocrinol. Metab., August 1, 1998; 83(8): 2836 - 2842. [Abstract] [Full Text]

				M. S. Gill, A. A. Toogood, P. A. O’Neill, M. O. Thorner, S. M. Shalet, and P. E. Clayton Urinary Growth Hormone (GH), Insulin-Like Growth Factor I (IGF-I), and IGF-Binding Protein-3 Measurements in the Diagnosis of Adult GH Deficiency J. Clin. Endocrinol. Metab., July 1, 1998; 83(7): 2562 - 2565. [Abstract] [Full Text]

				B. E. Engstrom, F. A. Karlsson, and L. Wide Marked gender differences in ambulatory morning growth hormone values in young adults Clin. Chem., June 1, 1998; 44(6): 1289 - 1295. [Abstract] [Full Text] [PDF]

				J. N. Roemmich, P. A. Clark, V. Mai, S. S. Berr, A. Weltman, J. D. Veldhuis, and A. D. Rogol Alterations in Growth and Body Composition During Puberty: III. Influence of Maturation, Gender, Body Composition, Fat Distribution, Aerobic Fitness, and Energy Expenditure on Nocturnal Growth Hormone Release J. Clin. Endocrinol. Metab., May 1, 1998; 83(5): 1440 - 1447. [Abstract] [Full Text]

				C. Fall, P. Hindmarsh, E. Dennison, S. Kellingray, D. Barker, and C. Cooper Programming of Growth Hormone Secretion and Bone Mineral Density in Elderly Men: A Hypothesis J. Clin. Endocrinol. Metab., January 1, 1998; 83(1): 135 - 139. [Abstract] [Full Text]

				M. Straume, M. L. Johnson, and J. D. Veldhuis Statistically accurate estimation of hormone concentrations and associated uncertainties: methodology, validation, and applications Clin. Chem., January 1, 1998; 44(1): 116 - 123. [Abstract] [Full Text] [PDF]

				I. M. Chapman, O. H. Pescovitz, G. Murphy, T. Treep, K. A. Cerchio, D. Krupa, B. Gertz, W. J. Polvino, E. H. Skiles, S. S. Pezzoli, et al. Oral Administration of Growth Hormone (GH) Releasing Peptide-Mimetic MK-677 Stimulates the GH/Insulin-Like Growth Factor-I Axis in Selected GH-Deficient Adults J. Clin. Endocrinol. Metab., October 1, 1997; 82(10): 3455 - 3463. [Abstract] [Full Text] [PDF]

				I. M. Chapman, M. L. Hartman, S. S. Pezzoli, F. E. Harrell Jr., R. L. Hintz, K. G. M. M. Alberti, and M. O. Thorner Effect of Aging on the Sensitivity of Growth Hormone Secretion to Insulin-Like Growth Factor-I Negative Feedback J. Clin. Endocrinol. Metab., September 1, 1997; 82(9): 2996 - 3004. [Abstract] [Full Text] [PDF]

				P. C. Hindmarsh, C. H. D. Fall, P. J. Pringle, C. Osmond, and C. G. D. Brook Peak and Trough Growth Hormone Concentrations Have Different Associations with the Insulin-Like Growth Factor Axis, Body Composition, and Metabolic Parameters J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2172 - 2176. [Abstract] [Full Text] [PDF]

				A. A. Toogood, R. M. Nass, S. S. Pezzoli, P. A. O'Neill, M. O. Thorner, and S. M. Shalet Preservation of Growth Hormone Pulsatility Despite Pituitary Pathology, Surgery, and Irradiation J. Clin. Endocrinol. Metab., July 1, 1997; 82(7): 2215 - 2221. [Abstract] [Full Text] [PDF]

				S. E. Kirk, B. J. Gertz, S. H. Schneider, M. L. Hartman, S. S. Pezzoli, J. M. Wittreich, D. A. Krupa, J. R. Seibold, and M. O. Thorner Effect of Obesity and Feeding on the Growth Hormone (GH) Response to the GH Secretagogue L-692,429 in Young Men J. Clin. Endocrinol. Metab., April 1, 1997; 82(4): 1154 - 1159. [Abstract] [Full Text] [PDF]

				P. Burman, A. G. Johansson, A. Siegbahn, B. Vessby, and F. A. Karlsson Growth Hormone (GH)-Deficient Men Are More Responsive to GH Replacement Therapy Than Women J. Clin. Endocrinol. Metab., February 1, 1997; 82(2): 550 - 555. [Abstract] [Full Text] [PDF]

				H. G. Maheshwari, S. S. Pezzoli, A. Rahim, S. M. Shalet, M. O. Thorner, and G. Baumann Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance Am J Physiol Endocrinol Metab, April 1, 2002; 282(4): E943 - E951. [Abstract] [Full Text] [PDF]